Therapeutic Response Evaluation and Adherence Trial (TREAT)

NCT02286154 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Anemia, Sickle Cell

Interventions

DRUG: Hydroxyurea

Sponsor

Children's Hospital Medical Center, Cincinnati